PDLI - PDL BioPharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts1122
Avg. Estimate0.080.06-0.520.12
Low Estimate0.080.06-0.530.1
High Estimate0.080.06-0.50.15
Year Ago EPS0.150.010.71-0.52
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts1122
Avg. Estimate46.08M35.35M194.22M122.96M
Low Estimate46.08M35.35M189.36M119.05M
High Estimate46.08M35.35M199.08M126.86M
Year Ago Sales68.04M38.52M320.06M194.22M
Sales Growth (year/est)-32.30%-8.20%-39.30%-36.70%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.0.030.090.060.07
EPS Actual0.150.01-0.760.18
Difference0.12-0.08-0.820.11
Surprise %400.00%-88.90%-1,366.70%157.10%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate0.080.06-0.520.12
7 Days Ago0.080.05-0.520.12
30 Days Ago0.080.05-0.520.12
60 Days Ago0.080.06-0.550.14
90 Days Ago0.070.04-0.60.12
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/A1N/AN/A
Up Last 30 DaysN/A1N/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesPDLIIndustrySectorS&P 500
Current Qtr.-46.70%N/AN/A0.12
Next Qtr.500.00%N/AN/A0.04
Current Year-173.20%N/AN/A0.18
Next Year123.10%N/AN/A0.08
Next 5 Years (per annum)14.00%N/AN/A0.12
Past 5 Years (per annum)-32.05%N/AN/AN/A